Introduction: why health information should be read critically
Thai Traditional Medicine knowledge includes material preserved in traditional texts, inherited practice, and professional experience, as well as topics that have later been investigated using contemporary scientific methods. These types of information answer different questions and should not be merged without clearly identifying their source and limits.
The World Health Organization (WHO) frames current development of traditional, complementary, and integrative medicine around evidence, safety, quality, regulation, people-centred care, and appropriate integration into health systems. Its Global Traditional Medicine Strategy 2025–2034 identifies strengthening the evidence base as a core objective.
1. What traditional texts and inherited knowledge can tell us
Traditional texts and inherited knowledge help explain how concepts, symptom patterns, herbs, procedures, and approaches to health have been described and transmitted within Thai Traditional Medicine. Such information is valuable for understanding history, culture, terminology, systems of thought, and professional practice.
However, the fact that a practice appears in a traditional text or has been used over time does not automatically demonstrate clinical effectiveness according to contemporary research standards, nor does it establish a biomedical mechanism.
2. What scientific research can tell us
Scientific research is designed to answer specific questions, such as whether an intervention changes an outcome, whether an exposure is associated with a condition, whether a treatment is safe, or whether a proposed mechanism is plausible. The strength of a conclusion depends on study design, sample size, measurement quality, control of bias and confounding, consistency across studies, and the relevance of the study population to the person or context of interest.
WHO’s recent strategy and research agenda for Traditional, Complementary and Integrative Medicine (TCIM) emphasize building evidence that can support decisions about safety, effectiveness, regulation, service delivery, and appropriate health-system integration.
3. Clinical observation is not the same as evidence of effectiveness
Observing that one person improved after receiving care may be useful for individual follow-up, but it does not by itself show that the intervention caused the improvement. Symptoms can change naturally, other factors may have contributed, and individual responses can vary.
Observational information can help generate research questions and identify patterns, but evaluating treatment effectiveness generally requires study designs that reduce bias and make appropriate comparisons.
4. Association is not the same as causation
When two factors occur together, one does not necessarily cause the other. A third factor may influence both, or the direction of the relationship may be different from what first appears. Health communication should therefore avoid turning “associated with” into “causes” unless the evidence supports a causal conclusion.
5. A plausible mechanism is not the same as proven clinical benefit
Laboratory research may suggest that an herb, compound, or procedure affects a cell pathway or biological process. Such findings can be scientifically useful, but they do not automatically prove that real-world use improves meaningful clinical outcomes in people.
Wording such as “may involve...” or “has been proposed to...” should be kept distinct from claims such as “treats,” “prevents,” or “has been proven effective.”
6. In vitro or animal research is not the same as human clinical evidence
Cell, laboratory, and animal studies play an important role in understanding possible mechanisms, toxicity, and research hypotheses. Their results may not translate directly to humans because dose, absorption, metabolism, exposure, and whole-body context differ.
For public communication, the study level should be stated plainly—for example, “observed in a laboratory study” rather than presenting a preclinical result as a demonstrated human clinical benefit.
7. A small study is not the final answer
Small studies can be useful for exploring feasibility or informing larger research, but results may be unstable and can change as more evidence becomes available. Interpretation should consider sample size, study quality, consistency across studies, and the findings of broader reviews.
8. How to read guidelines, government information, and reviews
Government documents, professional guidance, clinical guidelines, and systematic reviews can help summarize scattered evidence, but they should still be read with attention to publication date, target population, scope, evidence-selection methods, and stated limitations.
WHO describes appropriate TCIM integration as evidence-informed, culturally respectful, and adapted to national health systems. Recent global reports and research priorities also indicate that important evidence gaps remain in areas such as regulation, safety, service models, and policy implementation.
9. Applying evidence principles to herbs and procedures
Herbs and procedures should be assessed individually. “Natural” does not automatically mean “safe,” and traditional use does not eliminate the possibility of adverse effects. Safety sources such as the U.S. National Center for Complementary and Integrative Health (NCCIH) note that herbal products may interact with medicines, may differ from products studied in research, and may carry particular risks for people with certain conditions or around surgery.
- Identify the herb, plant part, formulation, and dose as precisely as possible.
- Consider current medicines, chronic conditions, pregnancy, breastfeeding, and surgery.
- Check contraindications, adverse effects, allergies, and potential herb–drug interactions.
- For procedures, consider practitioner qualifications, scope of practice, hygiene, and procedure-specific contraindications.
10. How to communicate when evidence is still limited
Professional communication does not require every topic to be assigned a public score or badge. When information is limited, plain language is often clearer:
- “Evidence on this question remains limited.”
- “Some studies are available, but the evidence is not yet sufficient for a broad conclusion.”
- “This description comes from Thai Traditional Medicine texts.”
- “A laboratory finding is not the same as a demonstrated clinical effect in humans.”
- “Potential benefits, risks, contraindications, and the individual’s health information should be considered together.”
This approach explains the status of information without using an Evidence Badge, Evidence Level, or five-level scoring system.
11. Traditional knowledge and scientific evidence have different roles
Traditional knowledge preserves ways of thinking, practice, language, cultural meaning, and accumulated experience. Scientific research tests specific questions using methods designed for transparency, comparison, and replication. The two should not be treated as interchangeable, but they can be studied together while preserving the boundaries of each knowledge system.
WHO’s current strategy similarly combines respect for cultural context and community rights with stronger evidence, safety, quality, regulation, and appropriate integration.
12. Summary: using health information appropriately
Critical reading of Thai Traditional Medicine information is not about dismissing traditional knowledge, nor is it about treating modern research as the only meaningful form of knowledge. It means understanding where information comes from, what question it answers, what its limitations are, and where it can appropriately be used.
For a clinic website, the practical standard is to identify information sources, match wording to what those sources actually support, avoid overclaiming, and keep reader and patient safety central.
References
- World Health Organization. Global Traditional Medicine Strategy 2025–2034. WHO; 2025. Used for current principles relating to evidence, safety, regulation, health-system integration, and people-centred care.
- World Health Organization. Traditional, Complementary and Integrative Medicine. WHO Health Topics. Used for current terminology and WHO policy direction.
- World Health Organization. WHO Global Research Priorities and Agenda for Traditional, Complementary and Integrative Medicine 2025–2034. WHO; 2026. Used for current evidence gaps and research priorities relating to safety, regulation, services, and policy.
- World Health Organization. WHO Global Report on Traditional, Complementary and Integrative Medicine 2024. WHO; 2025. Used for current global context on governance, workforce, herbal medicines, research, and service models.
- National Center for Complementary and Integrative Health (NCCIH). Dietary and Herbal Supplements and Safe Use of Complementary Health Products and Practices. Used for general safety considerations, product variability, and potential interactions between herbal products and medicines.
Health Information and Safety
This article is provided for general education about Thai traditional medicine and health. It is not a substitute for diagnosis, treatment, or individualized advice from a qualified health professional.
